Mass General researcher Matt Rosen, PhD, is all too familiar with the devastating effects of a late breast cancer diagnosis.
Mass General researcher Matt Rosen, PhD, is all too familiar with the devastating effects of a late breast cancer diagnosis.
The unrestricted funding provided by the MGH Research Scholar awards is enabling creative new approaches to cancer research.
A recent study both validated time to surgery as a standardized metric for breast cancer care and identified a worrying difference in time to surgery between Black and white patients.
How Daniel Faden, MD, and his team are working on developing and applying blood based cancer diagnostic tools.
It took contributions from almost 100 people to translate promising lab findings into a first-in-human treatment for glioblastoma.
Genevieve Boland, MD, PhD, a physician-investigator in the Cancer Center at Mass General, is researching skin cancer and related diseases.
A close-up look at the Demehri Lab and how they are working to understand the immune system’s role in early cancer development.
A Mass General oncologist has designed an iPad app to help patients navigate the challenges of acute myeloid leukemia treatment.
Dr. Bahl is using artificial intelligence (AI) and deep learning (DL) to improve the detection, diagnosis, and treatment of breast cancer.
The findings highlight the need for more initiatives to recruit and retain individuals from underrepresented groups.